Zhongchao Inc. Announces 1-for-31 Share Consolidation
SHANGHAI, June 4, 2026 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services for patients with cancer and other major diseases, today announced that the Company will effectuate a 1-for-31 share consolidation of the Company's ordinary shares of US$0.008 par value each (the "Share Consolidation"). Beginning with the opening of...
Innovative Drug Update | Kexing Biopharm Enrolls First Subject in China-based Phase I Clinical Trial of Ophthalmic Innovative Drug GB10
SHENZHEN, China, June 4, 2026 /PRNewswire/ -- Recently, the first subject was enrolled and dosed in the Phase I clinical trial in China for GB10 Injection, an innovative ophthalmic drug independently developed by Shenzhen Kexing Pharmaceutical Co., Ltd. ("Shenzhen Kexing"), a wholly-owned subsidiary of Kexing Biopharm. Designed to treat neovascular age-related macular degeneration (nAMD), the progress of GB10...
Everest Medicines Enters Commercialization License Agreement with Mabworks for Bejescin® in the Asia-Pacific Market
Everest Medicines has obtained exclusive rights for the clinical development and commercialization of Bejescin® (MIL62, Obinutuzumab beta Injection) across the Asia-Pacific region, including Southeast Asia, India, South Korea, Australia, New Zealand, Hong Kong SAR, Macao SAR, and Taiwan region, China. Under the terms of the agreement, Everest Medicines will pay Mabworks an upfront payment of RMB 23...
Waterdrop Inc. to Report First Quarter 2026 Financial Results on June 16, 2026
BEIJING, June 4, 2026 /PRNewswire/ -- Waterdrop Inc. (NYSE: WDH) ("Waterdrop" or the "Company"), a leading technology platform dedicated to insurance and healthcare service with a positive social impact, today announced that it will report its unaudited financial results for the first quarter ended March 31, 2026, before U.S. markets open on Tuesday, June 16, 2026. Waterdrop's management team will...
Delta Thailand Showcases Integrated Building Automation Solutions for Smarter, Healthier and More Sustainable Spaces at NOVA Expo 2026
BANGKOK, June 4, 2026 /PRNewswire/ -- Delta Electronics (Thailand) Public Company Limited, a global leader in power management and smart green solutions, is presenting its integrated building automation solutions at NOVA Expo 2026, Booth V9, EH103 Hall. The showcase highlights an integrated building automation ecosystem for two key vertical applications: hospitality and healthcare, including connected indoor air quality...
World’s First CLDN18.2 ADC for Regulatory Review: Innovent Biologics Announces IBI343 (arcotatug tavatecan) Met Primary Endpoint in International Phase 3 Study in Advanced Refractory Gastric Cancer and NDA Accepted...
SAN FRANCISCO and SUZHOU, China, June 4, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology and other major diseases, announces that the international multi-center Phase 3 clinical study (G-HOPE-001, NCT06238843) of arcotatug tavatecan (IBI343; Takeda...
Lupeng Pharmaceutical’s Fourth-Generation BTK Inhibitor Rocbrutinib Approved in China for Relapsed or Refractory Mantle Cell Lymphoma
GUANGZHOU, China, June 4, 2026 /PRNewswire/ -- Lupeng Pharmaceutical today announced that the National Medical Products Administration (NMPA) has granted accelerated approval to rocbrutinib (development code: LP-168) for the treatment of adult patients with relapsed or refractory mantle cell lymphoma (R/R MCL) who have received at least two prior systemic therapies, including BTK inhibitors. Rocbrutinib, independently developed by...
111, Inc. Announces First Quarter 2026 Unaudited Financial Results
Continuing Transition toward a More Asset-Light and Operationally Efficient Business Model Net Revenue of Promotional Products (1) Increased by 70.2% and Gross Profit Rose by 75.0% Year-over-Year Total Marketplace (MP) Service Revenue Increased by 24.7% Year-over-Year Fulfillment Expenses as a Percentage of Revenue Improved by 10 Basis Points Year-over-Year SHANGHAI, June 4, 2026 /PRNewswire/ -- 111,...
TelkomMetra Strengthens Its Business Portfolio Restructuring Strategy, AdMedika Group Ready for Distinct Expansion under Fullerton Health
This strategic initiative aligns with Danantara Indonesia's streamlining directive to TelkomGroup in strengthening its structure and sharpening its business focus. JAKARTA, Indonesia, June 4, 2026 /PRNewswire/ -- PT Multimedia Nusantara (TelkomMetra), an operating company of PT Telkom Indonesia (Persero) Tbk (Telkom), has officially signed a Shares Sale and Purchase Agreement (SPA) with the Fullerton Health group of companies...
2026 World Cup: Global Health Leaders Demand FIFA End its Coca-Cola Partnership – Vital Strategies
NEW YORK, June 4, 2026 /PRNewswire/ -- A formidable coalition of global health experts and advocates is demanding FIFA commit to ending its partnership with Coca-Cola by 2030. The Kick Big Soda Out movement first targeted FIFA during the 2025 Club World Cup in the United States—where campaigners accused Coca-Cola of sportswashing its health and environmental harms across stadiums,...
